Summit Therapeutics and GSK form collaboration to study ivonescimab combination therapy

Summit Therapeutics submits FDA application for ivonescimab in EGFR-mutated lung cancer

Clover Biopharmaceuticals enrols first participants in Phase 2 trial of respiratory combination vaccine candidates

Antin to acquire clinical trial equipment provider Emsere

Merck completes acquisition of Cidara Therapeutics for USD9.2bn

Bambusa Therapeutics reports first patient dosed in proof-of-concept COPD trial

Kelun-Biotech lung cancer drug granted Breakthrough Therapy Designation in China

INOVIO's INO-3107 Biologics License Application accepted by US FDA

Italfarmaco and JCR PHarmaceuticals strike Japan deal for givinostat and expand rare disease collaboration

Sanofi and Regeneron's Dupixent gains Japan approval for paediatric asthma patients aged 6 to 11

Aqualung Therapeutics' Phase 2a lung fibrosis study approved by US FDA

Faron launches BLAZE trial with Institute of Cancer Research to address immunotherapy resistance

GSK agrees US pricing framework to expand access to respiratory medicines

Century Health partnerss with Tessel Biosciences to advance early drug development in COPD

Sanofi's efdoralprin alfa receives EU orphan designation for AATD-related emphysema